Historical Newspapers of South Carolina

Below is the OCR text representation for this newspapers page. It is also available as plain text as well as XML.

Class CONTINUED FROM PAGE 1 heads up the Bioterrorism, Surveillance, and Response Program at DHEC, told students how South Carolina would re spond to a terrorist attack. Peter Sederberg, Honors College d^an and government and international studies profes sor, is scheduled to lecture twice this semester. Sederberg is well known for his expertise in the terrorism field and has published many books about the subject. Three of his books are on the course's recommended reading list. "I indicated that I would be willing to contribute because, as one of several faculty at this uni versity that actually has done re search in the area, I probably should be involved," he said. In his first lecture, "Defining Terrorism: Rhetorical Club or Empirical Concept," Sederberg hopes to give the students a gen eral overview of the topic and to "cast some light on a rather murky and obscure subject.", . He described his second lec ture, "Terrorism: Challenge and Response," as a "conceptual scheme for understanding the range of possible response to ter rorist attacks, and how to deter mine what might be the more ap propriate one given the circum stances." Other lecturers include histo ry professor Dan Carter, religious studies professor Hal French, and special agent Mike Anders from the State Law Enforcement Division. "As cities across the nation confront the risks from terrorist attacks, this course will help USC students explore the complexities of terrorism and understand the role they may play one day in the battle," Johnson said. Comments on this story?E-mail gamecockudesk@hotmail.com POLICE REPORT Each number on the map stands for a crime corresponding with numbered descriptions in the list below. DAY CRIMES (6 a.m.-6 p.m.) □ Violent O Nonviolent NIGHT CRIMES (6 p.m.-6 a.m.) ■ Violent # Nonviolent CRIMES AT UNKNOWN HOURS □ Violent Q Nonviolent Thursday, Feb. 7 ® ASSISTING OTHER AGENCY, LONGSTREET THEATRE Florida State University Police Department requested information pertaining to visits of the Florida State University Debate Team from January 1998 through December 2001 in connection with a criminal investigation. Reporting officer: Snyder. (D SUSPICIOUS ACTIVITY, 315 MAIN ST. The complainant said she encountered some "odd" behavior from two subjects in the Swearingen Engineering Center. The complainant provided a written statement. Reporting officer: J. A. Clarke. Monday, Feb. 11 ® LARCENY OF AIR COMPRESSOR, 1328 WHEAT ST. Campus Recreation said someone took a red and black "Sanhom" air compressor from the pool area at the Blatt P.E. Center. Estimated value: $525. Reporting officer: C. Taylor. Tuesday, Feb. 12 O GAS LEAK, 712 MAIN ST. The complainant said that there was a gas leak in the Jones Physical Science Center. The Health and Safety Department was notified. The Columbia Fire Department responded to the scene and checked the area. Maintenance shut off the gas to the affected area. Reporting officer: M. P. Moore. ® ASSAULT AND BATTERY, 1328 WHEAT ST. The reporting officer arrived at the Blatt P.E. Center to find the victim a cut above his swollen left eye. The victim was very uncooperative and refused to tell what happened. The victim also refused medical treatment from the first responder and did not want to press any charges against anyone. Reporting officer: C. Taylor, o ILLEGAL USE OF TELEPHONE, 614 BULL ST. The victim said an unknown male caller called and asked for her by name and then repeatedly asked her if she still wanted to buy marijuana. The victim said she didn’t know anyone by the name of "Jim," nor did she recognize the voice. A 3 a.m. pamphlet was issued and explained. Reporting officer: J. B. Coaxum. Wednesday, Feb. 13 ® LARCENYOFTOTE BAG, 710 ASSEMBLY ST. The victim said someone took his gray tote bag from an unsecured location in the Coliseum. The bag had "Geneva" inscribed on it. Other missing items include a "Legal Terminology" handbook, a "How Well Do You Know Your Bible?" handbook, a pair of work gloves and one house key on a key ring. Estimated value: $23. Reporting officer: J. D. Patterson. ® LOST PROPERTY, 1705 COLLEGE ST. The victim said she had turned offtier Nokia cell phone before class. After class she went to turn her cell phone back on and it was gone. Reporting officer: C. N. Ettenger. o N0N-SUSPICI0US FIRE, 902 BARNWELL ST. The reporting officer responded to a call of fire at Capstone Hall. The cause of the fire was built-up lint in a dryer in the laundry room. The fire was located in the basement and elevator shaft No. 1. The fire area was isolated and contained. Reporting officer: J. A. Clarke. Full Story CONTINUED FROM PAGE 1 Serving in Student Senate for the past two years, Bornemann doesn’t plan to play around with his presidential powers. "I think that in Student Government itself, (we need) to raise the accountability and pro ductivity," he said. "I’m not going to be afraid to kick somebody off of Cabinet if they are not doing their work. I’ll tell you that right now. I want people that are on there who want to do their posi tion, not just their title." Bom in Alabama, Bornemann lived there for two years before moving with his family to Greenwood, where his father now serves as the chamber of com merce director. Growing up in small town USA, Bornemann spent most of his time playing golf and hanging out with friends. "There wasn’t much to do in Greenwood," he said. Raised as a Presbyterian, Bornemann’s older brother con verted to the B’ahai faith while in college. "It seems like the fit for him," Bornemann said. After graduating high school with a 3.8 GPA in a class of 20 stu dents, Bornemann’s claim to fame came was his 1480 on the SAT. Faced with a decision between Georgetown and USC, Bornemann decided he "needed someplace big," and came to Carolina. Entering his senior year, Bornemann is running on the platform of "Building Foundations for the Future." He plans to enact a safe ride transport system in as sociation with the Five Points Association, a plan he says is al ready in the works. Along with his safe ride pro posal, Bornemann takes a differ ent view on perhaps the hottest topic of debate between students and administration — parking. "I think there is not a lot we can do right now," he said. "What we really need to do is work with ad ministration with the master plan and try to get them to change things within the next five to 10 years to stop taking away parking. ... If it were up to me, I’d pour the asphalt myself and cover up every green space on campus." As far as long-term political as pirations, Bornemann sees him self involved in politics in some form in the future. "I’m keeping it in the back of my mind," he said. "It’s some thing that interests me, and some thing that I would definitely con sider making a run for in the fu ture.” The Bornemann File ♦ Third year finance and marketing student, age 20 ♦ Birthplace: Decatur, Ala. Currently lives in Greenwood ♦ Family: Parents Len and Lynn Bornemann. Brother, Lee, 26, and sister, Debbie, 28 ♦ Hobbies: Soccer, golf, basketball, tennis, eating, napping ♦ Past and present activities at USC: University Ambassadors, Business School Senator, Sigma Chi Fraternity, Judicial Board for Fraternity Council, Dance Marathon Morale Leader, Safety Committee, Clean Carolina Director ♦ Favorite Music: Classic rock, Led Zeppelin, Dave Matthews Band ♦ Favorite Book: “Undaunted Courage" by Stephen Ambrose ♦ Future goals: Law school, to study institutional or corporate law with a possible career in public service Comments on this story?E-mail gamecockudesk@hotmail.com IContraceptive lnjection| B^oorrtroijou-twnkaBoutjust+xBjear medroxyprogesterone acetate injectable suspension___ DEPO-PROVERA* Contraceptive Injection (medroxyprogesterone acetate injectable suspension. USP) This product is intended to prevent pregnancy, it does not protect against HIV infection (AIDS) and other sexually transmitted diseases. What is DEPO-PROVERA Contraceptive injection? DEPO-PROVERA Contraceptive Injection is a form of birth control that s oven as an intramuscular injection (a shot) in die buttock or- upper arm once every 3 months (13 weeks). To continue yom contraceptive protection, you must return for your next injection promptly at the end of .3 months (13 weeks). DEPO-PROVERA contains medroxyprogesterone acetate, a chemical similar to (but not the same as) the natural hormone progesterone, which is produced by your oraries during the second half of your menstrual cycle DEPO; PRO/ERA acts by preventing vour egg cels from opening. If an egg is not tefeased from the ovaries during *xx menstrual cycle, it cannot become fertilized by sperm and result in pregnancy. D£PO-PRCM:RA also causes changes at the lining of your uterus that make it less likely for pregnancy to occur. How effective Is DEPO-PROVERA Contraceptive Injection? The efficacy of DEPO-PROVERA Contraceptive Injection depends on following the recorrvnerded dosage schedJe exactly (see “How often do i get my shot of DEPO-PRuvERA Contraceptive injection’*}. To make sure you are not pregnant when you first get DEPO-PROVERA Contraceptive Injection, your first injection must be given ONLY during the first 5 days of a normd menstrual period: ONLY within the first 5 days after childbirth .f not breast-feed**; and. if exduwefy breast-feeding, ONLY at the sixth week after childbirth, it is a long-term injectable contraceptive when administered at 3-month (13-week) intervals. DEPO-PROVERA Contraceptive Section is over 99% effective, making it one of the most reliable methods of birth control available. This means that the average annual pregnancy rate is less than one for every 100 women who use DEPO-PRO/ERA. The effectiveness of most contraceptive methods depends to part on how retiabty each woman uses the method The effectiveness of DEPO-PROVERA depends only on the patient returning every 3 months {13 weeks) for her next rjection. Your health-care provider will help you compare DEPO-PROVERA with other contraceptive methods and give you the information you need m order to decide which contraceptive method is the right choice for you The fdowing table shows ttie percent of women who got pregnant while using dtfferer* lands of contraceptive methods, ft gives both the lowest expected rate of pregnancy (the rate expected m women who use each method exactly as it should be used] and the typical rate of pregnancy (wbth r“eludes women who became pregnant because they forgot to use then birth control or because they did not folow the directions exactly). Percent of Women Experiencing an Accidental Pregnancy In the Fleet Year of Conttnuoua Uae Lowest MethodExpected_ Typical MK'fWMRA . 0-3. 03 trnpifcimt (Norpbm)0£_0?* it^nait -tontoatxxi__ 0-20* Hale aerJuMtmn CM OdS_ Oral cxiiratepiWn (pS) -3 Combined 0.1 _ frogtstegen only__05__'; tub * 3 fYogpsiasert 2.0 _Copper T 38QA_0.8_.____ CorxJom (without spemxode)2J2^ OapTragm (vHh spernxeide)&>8 Cervical cap6 <8 Withdrawal4_ >8 ffrnudx. atotinenrei ?_ 20__ Spermicide done3•2» VagxulSpunp? used before chidbtrib 6 18 _used after cMdbrth_9__28_ Ho _I25L-25 $ou**r Trussellet at ObsttJ Gyr*xo>. f99Qt76S58-587. •From NomUnt package evn Who should not use DEPO-PROVERA Contraceptive Injection? Not a3 women shexid use DEPO-PROVERA. You should not use DEPO-PROVERA if you have any of the following conditions: • if you dunk you might be pregnant • if you have any vaginal bleeding witfiout a known reason • if you have had cancer of the breast • if you have had a stroke • if you have or have had blood dots (phlebitis) in your legs • if you have problems with your fever or liver disease • rf you are alWgsc to DEPO-PROVERA {medroxyprogesterone acetate or any of its other ingredients) What other things should I consider before using DEPO-PROVERA Contraceptive Injection? You w»tt f«ve a physical examination before your doctor describes DEPO-PROVERA It is important to tell your health-care provider if you have any of the following • a family history of breast cancer • an abnormal mammogram (breast x-ray), fibrocystic breast disease, breast nodules or lumps, or bleeding from your nipples ■ kidney Cbease ■ irregular or scanty menstrual periods • high blood pressure • migraine headaches • asthma • • epilepsy (convulsions or secur es) • diabetes or a famfy t*story of diabetes • a history of depression ' • if you are taking any prescription or over-the-counter medications This product is intended to prevent pregnancy. H does not protect against transmission of HIV (AIDS) and other sexually transmitted diseases such as chlamydia, genital herpes, genital warts, gonorrhea, hepatitis B, and syphihs. What if I want to become pregnant after using DEPO-PROVERA Contraceptive Injection? Because DEPO-PROVERA is a long-acting birth control method, it takes some time after your last injection for its effect to wear off Based on the results from a large study done m the United States, for women who stop using DEPO-PROVERA m order to become pregnant. *t * expected that about half of those wtx> become pregpant will do so m about 10 months after their last injection: about two fords of those who become pregnant wtfi do so ir* about 12 months; about 83% of those who become pregnant w*i do so r- about 15 months; and about 93% of those who become pregnant will do so m about 18 months after- their last injection. The length of time you use DEPOPRCVERA h* no effect on hew bngit takes you to become pregnant after you stop usng n What are the risks of using DEPO-PROVERA Contraceptive Injection? The^stde effect leportecf most frequently by women who use DEFp-PROVERA for contraception « a change m there normal menstrual cycle. During the first year of ustng DEPO-PROVERA. . you might have one or more of the following changes: irregular or unpredictable Weeding or spotting, an increase or decrease m menstrua Weeding, or no weeding at all. Unusually heavy or continuous bteecfing, however is not a usual effect of DEPO-PROVERA, and if this happens* yqu should see your health-care provider right away. With continued use of DEPO-PROVERA. weeding usually decreases, and many women stop having periods completely In cfen'ical studies of DEPO-PROVERA. 55% of the women studied reported no menstrual bleeding (amenorrtiea) after I year of use, and 68% of the women studied reported no menstrual bleeding after 2 years of use The reason that your periods stop is because DEPO-PROVERA causes a resting state in your ovaries. When your Ovanes do not release an egg monthly, the regular monthly growth of foe lining of your uteres does not occur arid, therefore, the bteedng that comes with your normal menstruation does not take place. When you stop using DEPO-PROVERA your menstrual period will usuaffy.fo time, return to its normal cycle. 2 Bone Minerd Qwnges Use of DEPO-PROVERA may be associated with a decrease in the amount of mineral stored n your bones. Thri could if xr ease your nsk of developing bone fractures The rate of bone mineral loss ;s greatest in the early years of DEPO-PROVERA use, but after that it begins to resemble the norma rate of age-related bone mineral loss. IGmcer Studies of women who have used different forms of contraception found that women who used DEPO-PROVERA for contraception had no iixreased overall nsk of developing cancer of the breast, ovary, uterus, cervix or fever However, women under 35 years of age whose first exposure to DEPO-PRCVERA. was wfth<n the previous 4 to 5 years may have a slightly increased nsk of developing breast cancer similar to that seen with cr3l contraceptives. You snodd discuss this with your health care provider 4 Unexpected Pregnancy Because DEPO-PROvERA is such an effective contraceptive method, the risk of accidental pregnancy for women who get their shots regularly (every 3 months [13 weeks]) is very tow. White there iuwe been reports of an increased risk of low birth weight and neonatal infant death or other health problems in infants conceived close to the time of injection, such pregnancies are uncommon. If you think you may f»ave become pregnant whue usmg DEPO-PROVERA. for contraception, see your health-care provider as soon as possible. SAtier^c Reactions Some women using DEPO-PROVERA Contraceptive Injection have reported severe and potemiaSy tife-thi evening a'iergic reactions known as anaphylaxis and anaphylactoid reactions. Symptoms include the sudden onset of hives or swelling and itching of the staa breathing difficulties, and a drop in blood pressure. 6.0tb& Risks Women who use hormone-based contraceptives may have an increased risk of blood dots or stroke. Also, if a contraceptive method fails, there is a possibkty that the fertilized egg wiB begin to develop outside of the uterus (ectopic pregnancy). While these events are rare, you should tdl your health-care provider if you have any of the problems fisted in the next section. What symptoms may signal problems while using DEPO-PROVERA Contraceptive Injection? Call your health-care provider immediately if ary of these problems occur foflewing an injection of DEPO- PROVERA: • sharp chest pam. coughing up of blood, or sudden shortness of breath (indicating a possible dot in the lung) • sudden severe headache or vomiting, doziness or fainting, problems with your eyesight or speech, weakness, or numbness >n an arm or feg (indicating a possible stroke) • severe pain or sweftng m the calf (indicating a possible dot m the teg) • unusually heavy vaginal Weeding • severe pan or tenderness m the lower abdominal area • persistent pain. pus. or Weeckng at the injection ate .. . . , What are the possible side effects of DEPO-PROVERA Contraceptive Injection? I Weight Gain You may experience a weight gain wftBe you are using DEPO-PROVERA. About two thrds of the women who used DEPO-PROVERA in cfinicai trials reported a weight g«n of about 5 pounds during the first year of use. You may continue to gam weight after the first year Women m one large study who used DEPO-PROVERA for 2 years gained an average total of 81 poinds over those 2 years, or approximately 4 pounds pet' year: Women who continued for 4 years gained an average total of 13-8 pounds over those 4 year s. or approximately 35 poinds per year. Women who continued for 6 years gained an average total of 165 pounds over those 6 years, or pounds per year. In a dirial study of over 3,900 women who used DEPO-PROVERA for up to 7 years, some women reported the following effects that may or may not have been related to their use of DEPO-PROVERA: h regUar menstrual Weeding, amenorrhea, headache, nervousness, abdominal cramps, dizaness. weakness or fatigue, decreased sexual des*e. leg cramps, nausea, vaginal discharge or inflation breast sweftng and tenderness, bloating, swelling of tt»e hands or feet, backache, depression, insomnia, acne, pelvic pain, no hair growth or excessive hair loss, rash, hot flashes, and joint pain Other problems were reported by very few of the women m the cfcmcaJ trials, but some of these could be serious These include convulsions, jaundice, urinary tract infections, allergic reactions. feinting. paralysis, osteoporosis, lack of return to ferWrty. deep vein thrombosis, pumonary embolus, breast cancer, or cervical cancer, ff these or any other problems occur during your use of DEPO-PROVERA. discuss them with your health-careprovider. Should any precautions be followed during use of DEPO-PROVERA Contraceptive Injection? 1 Missed fferiods During the time you ate using DEPO-PROVERA for contraception, you may stop a period, or your periods may stop completely. If you have been receiving your DEPO-PROVERA injections regularly every 3 months (13 weeks), then you are probably not pregnant However, if you think that you may be pregnant see your health-care provider. 2 Laboratory lest tnierocOons If you are scheduled for any laboratory tests, teil your heaRh-care provide' that you are using DEPO-PROVERA for contraception. Certain blood tests are affected by hormones such as DEPO-PROVERA. 3.0ru}intenxbom Cytadren (aminoclutettiimide) is an anticancer drug that may significantly decrease the effectiveness of DEPO-PROVERA if the two drugs are given during the same time. 4 Nursing Mothers Although DEPO-PROVERA can be passed to the nursing infant in the breast m»c no harmful effects nave been found m these cftldren. DEPO-PROVERA does not prevent the breasts from producing mi Be so it can be used by nursing mothers. However, to minimize the amount of DEPO-PROVERA that «s passed to the infant in the first weeks after birth, you should wart until 6 weeks after childbirth before you start using DEPO-PROVERA for contraception How often do I get my shot of DEPO-PROVERA Contraceptive Injection? The recommended dose of DEPO-PROVERA h ISO mg every 3 months (13 weeks) given m a single intramuscular injection in the buttock or upper arm To make surethatvou are not pregnant at the time of the first injection, it is essential that the injection be given ONLY during the first 5 days of a normal menstrual period If used following the delivery of a child, the first injection of DEPO-PROVERA MUST be given withn 5 days after childbirth if you are not breast-feeding or 6 weeks after childbirth if you are exclusively breast-feeding, if you wait longer than 3 months (13 weeks) between injections, or longer than 6 weeks after delivery, your health-care provider should determine that you are not pregnant before giving you your injection of DEPORROVERA. Rx only. CB-7-S • Pharmacia & Upjohn W 55 per student w. ID Tickets available at j 57 per non-student the RH Info desk M g vvith disabilities needing special accommodations please call 777-7130^